Clinical Trials Sponsored by Yantai Patronus Biotech Co., Ltd.

Total 656 results

Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

SARS-CoV-2 | COVID-19 Vaccine

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001

COVID-19
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

COVID-19

China
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

The Phase Ⅱ/Ⅲ Trial of LYB001

COVID-19
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001

COVID-19
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Withdrawn

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Afﬁliated Hospital of North Sichuan Medical College; Yantai Patronus Biotech...

Active, not recruiting

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Afﬁliated Hospital of North Sichuan Medical College; Yantai Patronus Biotech...

Active, not recruiting

The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001

COVID-19 | Vaccine Reaction

China
Yantai YenePharma Co., Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet

Intracranial Hemorrhages | Stroke, Acute

United States
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma (NOTABLE-307)

Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Safety and Preliminary Clinical Activity of Itolizumab in ARDS

Acute Respiratory Distress Syndrome
SunWay Biotech Co., LTD.

Recruiting

Effect of Vigiis 101 Lactic Acid Bacteria Powder on Body Weight and Body Fat in Overweight Participants

Overweight | Body Weight | Body Fat

Taiwan
Sinovac Biotech Co., Ltd

Recruiting

A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

Poliomyelitis | Polio

Pakistan, Bangladesh
Oneness Biotech Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma

Severe Asthma

Taiwan
Oneness Biotech Co., Ltd.

Recruiting

Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Chronic Diabetic Foot Ulcers

United States
Meridigen Biotech Co., Ltd.

Recruiting

Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).

Osteoarthritis, Knee

Taiwan
Oneness Biotech Co., Ltd.

Recruiting

Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies

Advanced Solid Malignancies

Taiwan
Eusol Biotech Co., Ltd.

Suspended

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury

Spinal Cord Injuries

Taiwan
Meridigen Biotech Co., Ltd.

Active, not recruiting

Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Moderate

Taiwan
Glac Biotech Co., Ltd

Completed

Effects of Probiotics Improves the Endurance and Explosiveness Exercise Performance on Healthy Human.

Exercise Performance

Taiwan
Everfront Biotech Co., Ltd.

Active, not recruiting

To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers

Amyotrophic Lateral Sclerosis

Taiwan
Biotech Pharmaceutical Co., Ltd.

Completed

A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN (Redbull-1)

Locally Advanced Head and Neck Squamous Cell Carcinoma

China
Transwell Biotech Co., Ltd.

Completed

TWB-103 for Treating Lower Limb Ulcers on Patients With DM

Diabetic Foot Ulcer

Taiwan
Trinomab Biotech Co., Ltd.

Completed

Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers

Tetanus

China
TransGen Biotech Co., LTD

Completed

SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study (CPS CW008)

COVID-19 | Coronavirus Disease 2019 | Diagnoses Disease | COVID-19 Pandemic

Spain
Sinovac Biotech Co., Ltd

Completed

Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months

Hand, Foot and Mouth Disease

China
Oneness Biotech Co., Ltd.

Completed

Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis

Atopic Dermatitis

Taiwan
Biotech Pharmaceutical Co., Ltd.

Completed

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

Esophageal

China
Sinovac Biotech Co., Ltd

Completed

Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)

Hepatitis B

China
Sinovac Biotech Co., Ltd

Completed

Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children

Hand-foot-mouth Disease | Infection; Viral, Enterovirus

China
Sinovac Biotech Co., Ltd

Completed

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

Hepatitis B | Hepatitis A

China
SunWay Biotech Co., LTD.

Completed

Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora

Gastrointestinal Microbiome

Taiwan
Sinovac Biotech Co., Ltd

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Seasonal Influenza

China
Sinovac Biotech Co., Ltd

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

Seasonal Influenza

China
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants

Poliomyelitis

China
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants

Poliomyelitis

China
Biosuccess Biotech Co., Ltd.

Terminated

Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome (AML/MDS)

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Sinovac Biotech Co., Ltd

Completed

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

Hand, Foot and Mouth Disease

China
Sinovac Biotech Co., Ltd

Completed

The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children

Hepatitis A

China
Biotech Pharmaceutical Co., Ltd.

Unknown

Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinomas

China
Biotech Pharmaceutical Co., Ltd.

Unknown

Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors

Solid Tumors

China
Sinovac Biotech Co., Ltd

Completed

Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults

Hepatitis A

China
SBI Biotech Co., Ltd.

Terminated

A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Leukemia

United States
Sinovac Biotech Co., Ltd

Completed

An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Hand, Foot and Mouth Disease

China
HealthBanks Biotech Co., Ltd.

Unknown

Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine

Cervical Intraepithelial Neoplasia
Dalim BioTech Co., Ltd.

Completed

A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components

Diabetes Mellitus, Type 2

Korea, Republic of
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines

Influenza

China

3

Subscribe